Stephane Peluso
2021
In 2021, Stephane Peluso earned a total compensation of $1.1M as Chief Scientific Officer at Infinity Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $596,400 |
| Salary | $169,231 |
| Stock Awards | $146,500 |
| Other | $9,109 |
| Total | $1,081,240 |
Peluso received $596.4K in option awards, accounting for 55% of the total pay in 2021.
Peluso also received $160K in non-equity incentive plan, $169.2K in salary, $146.5K in stock awards and $9.1K in other compensation.
Rankings
In 2021, Stephane Peluso's compensation ranked 8,524th out of 12,415 executives tracked by ExecPay. In other words, Peluso earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,524 out of 12,415 | 31st |
Division Manufacturing | 3,779 out of 5,505 | 31st |
Major group Chemicals And Allied Products | 1,674 out of 2,375 | 30th |
Industry group Drugs | 1,491 out of 2,096 | 29th |
Industry Pharmaceutical Preparations | 1,111 out of 1,546 | 28th |
Source: SEC filing on April 25, 2022.
Peluso's colleagues
We found two more compensation records of executives who worked with Stephane Peluso at Infinity Pharmaceuticals in 2021.